Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project
The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer...
Saved in:
Published in | Breast cancer research and treatment Vol. 131; no. 2; pp. 637 - 643 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Boston
Springer US
01.01.2012
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0167-6806 1573-7217 1573-7217 |
DOI | 10.1007/s10549-011-1770-1 |
Cover
Abstract | The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18–32 months) were pooled in the After Breast Cancer Pooling Project (
n
= 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (
n
= 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66–0.82) and a 25% reduction in breast cancer mortality (
n
= 971 events, HR = 0.75, 95% CI 0.65–0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence (
n
= 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86–1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors. |
---|---|
AbstractList | The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 hours (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18 to 32 months) were pooled in the After Breast Cancer Pooling Project (n=13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n=1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66–0.82) and a 25% reduction in breast cancer mortality (n=971 events, HR=0.75, 95% CI 0.65–0.85) compared to women who did not meet the PA Guidelines (< 10 MET-hours/week). Risk of breast cancer recurrence (n=1,421 events) was not associated with meeting the PA Guidelines (HR=0.96, 95% CI, 0.86–1.06). These data suggest that adhering to the PA Guidelines may be an important intervention target for reducing mortality among breast cancer survivors. The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18-32 months) were pooled in the After Breast Cancer Pooling Project (n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66-0.82) and a 25% reduction in breast cancer mortality (n = 971 events, HR = 0.75, 95% CI 0.65-0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence (n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86-1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors. The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18-32 months) were pooled in the After Breast Cancer Pooling Project (n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66-0.82) and a 25% reduction in breast cancer mortality (n = 971 events, HR = 0.75, 95% CI 0.65-0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence (n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86-1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors.The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18-32 months) were pooled in the After Breast Cancer Pooling Project (n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66-0.82) and a 25% reduction in breast cancer mortality (n = 971 events, HR = 0.75, 95% CI 0.65-0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence (n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86-1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors. The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18-32 months) were pooled in the After Breast Cancer Pooling Project (n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66-0.82) and a 25% reduction in breast cancer mortality (n = 971 events, HR = 0.75, 95% CI 0.65-0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence (n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86-1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors. Keywords Physical activity guidelines * Breast cancer survival * Mortality * Epidemiology The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18-32 months) were pooled in the After Breast Cancer Pooling Project (n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66-0.82) and a 25% reduction in breast cancer mortality (n = 971 events, HR = 0.75, 95% CI 0.65-0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence (n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86-1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors.[PUBLICATION ABSTRACT] The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18–32 months) were pooled in the After Breast Cancer Pooling Project ( n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality ( n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66–0.82) and a 25% reduction in breast cancer mortality ( n = 971 events, HR = 0.75, 95% CI 0.65–0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence ( n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86–1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors. |
Audience | Academic |
Author | Lu, Wei Weltzien, Erin K. Kroenke, Candyce H. Cadmus-Bertram, Lisa Beasley, Jeannette M. Patterson, Ruth E. Shu, Xiao-Ou Kwan, Marilyn L. Nechuta, Sarah J. Caan, Bette J. Chen, Wendy Y. Pierce, John P. Sternfeld, Barbara |
AuthorAffiliation | 4 Shanghai Center for Disease Control and Prevention, Shanghai, China 2 Kaiser Permanente Division of Research, Oakland, CA 94612 5 Vanderbilt University, Nashville, TN 37203 3 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 6 Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, San Diego, CA 92093 1 Fred Hutchinson Cancer Research Center, Seattle, WA 98109 |
AuthorAffiliation_xml | – name: 3 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA – name: 2 Kaiser Permanente Division of Research, Oakland, CA 94612 – name: 5 Vanderbilt University, Nashville, TN 37203 – name: 6 Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, San Diego, CA 92093 – name: 4 Shanghai Center for Disease Control and Prevention, Shanghai, China – name: 1 Fred Hutchinson Cancer Research Center, Seattle, WA 98109 |
Author_xml | – sequence: 1 givenname: Jeannette M. surname: Beasley fullname: Beasley, Jeannette M. email: jbeasley@whi.org organization: Fred Hutchinson Cancer Research Center – sequence: 2 givenname: Marilyn L. surname: Kwan fullname: Kwan, Marilyn L. organization: Kaiser Permanente Division of Research – sequence: 3 givenname: Wendy Y. surname: Chen fullname: Chen, Wendy Y. organization: Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School – sequence: 4 givenname: Erin K. surname: Weltzien fullname: Weltzien, Erin K. organization: Kaiser Permanente Division of Research – sequence: 5 givenname: Candyce H. surname: Kroenke fullname: Kroenke, Candyce H. organization: Kaiser Permanente Division of Research – sequence: 6 givenname: Wei surname: Lu fullname: Lu, Wei organization: Shanghai Center for Disease Control and Prevention – sequence: 7 givenname: Sarah J. surname: Nechuta fullname: Nechuta, Sarah J. organization: Vanderbilt University – sequence: 8 givenname: Lisa surname: Cadmus-Bertram fullname: Cadmus-Bertram, Lisa organization: Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California – sequence: 9 givenname: Ruth E. surname: Patterson fullname: Patterson, Ruth E. organization: Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California – sequence: 10 givenname: Barbara surname: Sternfeld fullname: Sternfeld, Barbara organization: Kaiser Permanente Division of Research – sequence: 11 givenname: Xiao-Ou surname: Shu fullname: Shu, Xiao-Ou organization: Vanderbilt University – sequence: 12 givenname: John P. surname: Pierce fullname: Pierce, John P. organization: Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California – sequence: 13 givenname: Bette J. surname: Caan fullname: Caan, Bette J. organization: Kaiser Permanente Division of Research |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25422632$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21935600$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk9vEzEQxS1URNPAB-CCVqACly22d72OOSBVFf-kIi5wtrzeceJoY6e2N1JufPR6SWibqlQ-rGT_3pvZmXeCjpx3gNBLgs8IxvxDJJjVosSElIRzXJInaEIYr0pOCT9CE0waXjYz3ByjkxiXGGPBsXiGjikRFWswnqA_PwCSdfMiLaBYL7bRatUXSie7sWlbzAfbQW8dxEK5rohD2NjNCJgEoWgDqJgKrZyG8LEw1nXZKhYm-NVfwwewYu19PxZcB78EnZ6jp0b1EV7sv1P0-8vnXxffysufX79fnF-WumE0lUZgAppThnXV1s2s5czwulVGC0aIEqqFGgvDhOoaXc2aiqq2VRgDbnjLKa2m6NPOdz20K-g0uBRUL9fBrlTYSq-sPHxxdiHnfiMrymnVjAbv9gbBXw0Qk1zZqKHvlQM_RClIletQITL5_lGS1GzGKOe5yyl6fQ9d-iG4PIjRryKCMZyhNztornqQ1hmfG9SjpzzPa2QzgpuROnuAyqeDldU5OMbm-wPB2zuCBag-LaLvh2S9i4fgq7uju5nZvxRl4HQPqJjjY0LetI23HKspzRvJHNlxOvgYA5gbhGA5JlruEi1zouWYaEmyht_TaJvU2GP-Pds_qqQ7ZcxV3BzC7Wz_L7oGkZAI4g |
CODEN | BCTRD6 |
CitedBy_id | crossref_primary_10_1186_s12885_015_1971_9 crossref_primary_10_1007_s10549_012_2274_3 crossref_primary_10_1007_s10549_016_3970_1 crossref_primary_10_1177_15347354221140327 crossref_primary_10_3390_ijms24054974 crossref_primary_10_1097_SGA_0000000000000252 crossref_primary_10_1158_1078_0432_CCR_16_0067 crossref_primary_10_1002_ijc_28130 crossref_primary_10_3390_ijerph110505487 crossref_primary_10_3390_ijerph20064872 crossref_primary_10_1136_bmjopen_2022_062288 crossref_primary_10_1093_jnci_djaa046 crossref_primary_10_1136_bmjopen_2023_076321 crossref_primary_10_3389_fonc_2020_563566 crossref_primary_10_1007_s13668_011_0004_9 crossref_primary_10_1007_s00520_013_2065_3 crossref_primary_10_1158_0008_5472_CAN_15_3307 crossref_primary_10_3390_cancers11010062 crossref_primary_10_1007_s10654_014_9916_1 crossref_primary_10_1360_SSV_2022_0235 crossref_primary_10_1007_s11764_015_0441_3 crossref_primary_10_3109_0284186X_2014_998275 crossref_primary_10_1200_JCO_23_01959 crossref_primary_10_1016_j_breast_2021_05_004 crossref_primary_10_1007_s40615_022_01405_4 crossref_primary_10_1136_bmjopen_2018_026797 crossref_primary_10_1016_j_ypmed_2017_05_029 crossref_primary_10_1249_MSS_0000000000002539 crossref_primary_10_1007_s00520_021_06706_8 crossref_primary_10_1016_j_cct_2020_106001 crossref_primary_10_1136_bmjopen_2019_032871 crossref_primary_10_1016_j_cct_2021_106524 crossref_primary_10_1093_annonc_mdu012 crossref_primary_10_1123_jpah_2019_0037 crossref_primary_10_1038_s41568_019_0145_5 crossref_primary_10_1097_PPO_0000000000000405 crossref_primary_10_1158_1055_9965_EPI_22_1274 crossref_primary_10_1016_j_critrevonc_2014_12_012 crossref_primary_10_1007_s11764_021_01104_9 crossref_primary_10_1080_14635240_2021_2004438 crossref_primary_10_4048_jbc_2022_25_e42 crossref_primary_10_1007_s10552_013_0252_7 crossref_primary_10_1089_acm_2014_0061 crossref_primary_10_1089_act_2015_29006_cr crossref_primary_10_1016_j_ygyno_2018_01_020 crossref_primary_10_3389_fonc_2024_1393902 crossref_primary_10_1007_s11845_021_02785_y crossref_primary_10_1017_S0029665118000010 crossref_primary_10_1007_s10269_015_2582_4 crossref_primary_10_1093_jncimonographs_lgad011 crossref_primary_10_3390_ijerph20065197 crossref_primary_10_3390_cancers13215329 crossref_primary_10_1002_ijc_34324 crossref_primary_10_1002_14651858_CD011292 crossref_primary_10_1097_NCC_0000000000000580 crossref_primary_10_1016_j_revmed_2015_12_021 crossref_primary_10_1177_1534735417731514 crossref_primary_10_1177_1534735420943269 crossref_primary_10_1007_s12609_014_0147_y crossref_primary_10_3109_09593985_2015_1004390 crossref_primary_10_1007_s10552_016_0726_5 crossref_primary_10_1186_s12885_016_2244_y crossref_primary_10_1186_s40064_015_0912_z crossref_primary_10_1016_j_bulcan_2020_07_003 crossref_primary_10_1111_ajco_13834 crossref_primary_10_1002_cncr_30440 crossref_primary_10_15430_JCP_2013_18_3_193 crossref_primary_10_2217_fon_2017_0037 crossref_primary_10_1007_s10903_018_0721_x crossref_primary_10_1007_s11764_020_00856_0 crossref_primary_10_1002_ijc_29940 crossref_primary_10_1093_jncics_pkz080 crossref_primary_10_1002_14651858_CD011292_pub2 crossref_primary_10_1007_s10549_014_3216_z crossref_primary_10_1007_s10552_014_0431_1 crossref_primary_10_1007_s00520_014_2346_5 crossref_primary_10_1007_s10552_022_01663_x crossref_primary_10_3390_cancers14071756 crossref_primary_10_1002_cncr_28630 crossref_primary_10_1586_erp_12_37 crossref_primary_10_1016_j_pranut_2021_06_005 crossref_primary_10_1007_s10552_013_0294_x crossref_primary_10_1016_j_ijnurstu_2018_12_002 crossref_primary_10_1007_s12094_020_02388_6 crossref_primary_10_1016_j_canep_2015_03_009 crossref_primary_10_1097_EDE_0000000000000933 crossref_primary_10_1188_20_ONF_703_719 crossref_primary_10_1002_ijc_28740 crossref_primary_10_1097_EDE_0000000000000373 crossref_primary_10_31083_j_rcm2406160 crossref_primary_10_17650_1994_4098_2022_18_3_40_51 crossref_primary_10_1007_s11764_013_0265_y crossref_primary_10_1093_jnci_djs473 crossref_primary_10_1016_j_puhe_2016_03_028 crossref_primary_10_1016_j_ejca_2016_10_025 crossref_primary_10_1093_epirev_mxx007 crossref_primary_10_1186_1471_2407_13_153 crossref_primary_10_1016_j_breast_2019_02_001 crossref_primary_10_1016_j_ejca_2016_07_010 crossref_primary_10_3322_caac_21405 crossref_primary_10_4048_jbc_2014_17_3_189 crossref_primary_10_1111_ecc_12617 crossref_primary_10_1001_jamanetworkopen_2021_3520 crossref_primary_10_3389_fpubh_2017_00019 crossref_primary_10_1016_j_bulcan_2020_06_013 crossref_primary_10_3390_cancers13236056 crossref_primary_10_1200_EDBK_432564 crossref_primary_10_1007_s00520_014_2185_4 crossref_primary_10_1007_s00520_020_05344_w crossref_primary_10_1002_cncr_29786 crossref_primary_10_1007_s13668_013_0067_x crossref_primary_10_1159_000356172 crossref_primary_10_1007_s13668_022_00431_2 crossref_primary_10_1111_ecc_13037 crossref_primary_10_3390_ijerph181910052 crossref_primary_10_1007_s00520_024_08831_6 crossref_primary_10_1249_MSS_0000000000001937 crossref_primary_10_1002_cam4_1847 crossref_primary_10_29328_journal_jsmt_1001034 crossref_primary_10_15829_1728_8800_2022_3235 crossref_primary_10_1007_s10269_015_2539_7 crossref_primary_10_1007_s12282_020_01211_y crossref_primary_10_1007_s10269_016_2587_7 crossref_primary_10_1186_1748_5908_8_77 crossref_primary_10_3109_09593985_2015_1037409 crossref_primary_10_1159_000356044 crossref_primary_10_3390_nu15194245 crossref_primary_10_1007_s10549_014_2966_y crossref_primary_10_1007_s12094_020_02312_y crossref_primary_10_1017_S0029665118000447 |
Cites_doi | 10.1007/s10552-010-9714-3 10.1093/ije/23.5.991 10.1158/1055-9965.EPI-08-0595 10.1093/aje/kwj127 10.1200/JCO.2006.08.6819 10.1007/s10552-011-9805-9 10.1016/S0197-2456(02)00241-6 10.1002/ijc.24155 10.1001/jama.293.20.2479 10.1001/jama.2009.1783 10.3138/physio.62.1.25 10.1016/0197-2456(86)90046-2 10.1097/00005768-200111000-00024 10.1249/00005768-199301000-00011 10.1200/JCO.2010.27.9752 10.1007/s10552-004-8340-3 10.1016/j.maturitas.2010.01.004 10.1158/1055-9965.EPI-07-0771 10.1038/nrc1608 10.1249/MSS.0b013e3181e0c112 10.1093/aje/kwg255 10.1158/1940-6207.CAPR-10-0295 10.5993/AJHB.31.2.8 10.1111/j.1753-4887.2008.00136.x 10.1158/1055-9965.1163.13.7 10.1007/s12032-010-9536-x |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, LLC. 2011 2015 INIST-CNRS COPYRIGHT 2012 Springer Springer Science+Business Media, LLC. 2012 |
Copyright_xml | – notice: Springer Science+Business Media, LLC. 2011 – notice: 2015 INIST-CNRS – notice: COPYRIGHT 2012 Springer – notice: Springer Science+Business Media, LLC. 2012 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 K9- K9. M0R M0S M1P M2O MBDVC PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7TS 7X8 5PM |
DOI | 10.1007/s10549-011-1770-1 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Consumer Health Database ProQuest Health & Medical Collection Medical Database ProQuest Research Library Research Library (Corporate) Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic Physical Education Index MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Physical Education Index MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Physical Education Index MEDLINE Research Library Prep |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1573-7217 |
EndPage | 643 |
ExternalDocumentID | PMC3272362 2551526421 A356581060 21935600 25422632 10_1007_s10549_011_1770_1 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: 3R01CA118229-03S1 – fundername: NCI NIH HHS grantid: P01 CA087969 – fundername: NCI NIH HHS grantid: R01 CA118229 – fundername: NCI NIH HHS grantid: R01 CA129059 – fundername: NCI NIH HHS grantid: P01 CA87969 – fundername: National Cancer Institute : NCI grantid: R01 CA129059-04 || CA |
GroupedDBID | --- -53 -5E -5G -BR -EM -XW -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 23N 28- 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHVE ACHXU ACIHN ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEAQA AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFFNX AFJLC AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BKNYI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GRRUI GUQSH GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO ICW IHE IHR IHW IJ- IKXTQ IMOTQ INH INR ITC ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ K9- KDC KOV KOW KPH LAK LLZTM M0R M1P M2O M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UDS UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z7W Z81 Z82 Z83 Z87 Z8O Z8Q Z8U Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ IQODW PJZUB PPXIY CGR CUY CVF ECM EIF NPM AEIIB PMFND 7TO 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQUKI Q9U 7TS PUEGO 7X8 5PM |
ID | FETCH-LOGICAL-c652t-f901ec7250c3b468b75f74bafc9511a9abe409f59ad6c38632abba00e067b7223 |
IEDL.DBID | 8C1 |
ISSN | 0167-6806 1573-7217 |
IngestDate | Thu Aug 21 18:12:07 EDT 2025 Fri Sep 05 02:54:31 EDT 2025 Thu Sep 04 23:34:54 EDT 2025 Fri Aug 15 19:41:42 EDT 2025 Tue Jun 17 21:06:47 EDT 2025 Tue Jun 10 20:22:10 EDT 2025 Thu May 22 21:23:26 EDT 2025 Mon Jul 21 06:03:06 EDT 2025 Mon Jul 21 09:14:22 EDT 2025 Tue Jul 01 03:37:40 EDT 2025 Thu Apr 24 23:01:34 EDT 2025 Fri Feb 21 02:33:51 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Physical activity guidelines Breast cancer survival Epidemiology Mortality Physical exercise Human Breast disease Breast cancer Malignant tumor Survival Recommendation Mammary gland diseases Project Public health Cancer |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c652t-f901ec7250c3b468b75f74bafc9511a9abe409f59ad6c38632abba00e067b7223 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 21935600 |
PQID | 913319550 |
PQPubID | 36266 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3272362 proquest_miscellaneous_913722299 proquest_miscellaneous_1458527786 proquest_journals_913319550 gale_infotracmisc_A356581060 gale_infotracacademiconefile_A356581060 gale_healthsolutions_A356581060 pubmed_primary_21935600 pascalfrancis_primary_25422632 crossref_primary_10_1007_s10549_011_1770_1 crossref_citationtrail_10_1007_s10549_011_1770_1 springer_journals_10_1007_s10549_011_1770_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-01-01 |
PublicationDateYYYYMMDD | 2012-01-01 |
PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Boston |
PublicationPlace_xml | – name: Boston – name: Dordrecht – name: Netherlands |
PublicationTitle | Breast cancer research and treatment |
PublicationTitleAbbrev | Breast Cancer Res Treat |
PublicationTitleAlternate | Breast Cancer Res Treat |
PublicationYear | 2012 |
Publisher | Springer US Springer Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer – name: Springer Nature B.V |
References | Holmes (CR11) 2005; 293 Irwin, McTiernan, Manson, Thomson, Sternfeld, Stefanick, Wactawski-Wende, Craft, Lane, Martin, Chlebowski (CR23) 2011; 4 CR19 Johnson-Kozlow, Rock, Gilpin, Hollenbach, Pierce (CR14) 2007; 31 Bertram, Stefanick, Saquib, Natarajan, Patterson, Bardwell, Flatt, Newman, Rock, Thomson, Pierce (CR28) 2011; 22 Cheifetz, Moore, Brooks, Barbaric (CR4) 2010; 62 Borugian, Sheps, Kim-Sing, Van Patten, Potter, Dunn, Gallagher, Hislop (CR20) 2004; 13 Pierce, Stefanick, Flatt, Natarajan, Sternfeld, Madlensky, Al-Delaimy, Thomson, Kealey, Hajek, Parker, Newman, Caan, Rock (CR21) 2007; 25 Staten, Taren, Howell, Tobar, Poehlman, Hill, Reid, Ritenbaugh (CR10) 2001; 33 Friedenreich, Gregory, Kopciuk, Mackey, Courneya (CR22) 2009; 124 Ainsworth, Haskell, Leon, Jacobs, Montoye, Sallis, Paffenbarger (CR15) 1993; 25 Shu, Zheng, Cai, Gu, Chen, Zheng, Lu (CR9) 2009; 302 Holick, Newcomb, Trentham-Dietz, Titus-Ernstoff, Bersch, Stampfer, Baron, Egan, Willett (CR27) 2008; 17 Caan, Sternfeld, Gunderson, Coates, Quesenberry, Slattery (CR6) 2005; 16 CR2 CR3 Matthews, Shu, Yang, Jin, Ainsworth, Liu, Gao, Zheng (CR13) 2003; 158 Smith-Warner (CR16) 2006; 163 Colditz, Hankinson (CR8) 2005; 5 DerSimonian, Laird (CR17) 1986; 7 Schmitz, Courneya, Matthews, Demark-Wahnefried, Galvao, Pinto, Irwin, Wolin, Segal, Lucia, Schneider, von Gruenigen, Schwartz (CR25) 2010; 42 Nechuta, Caan, Chen, Flatt, Lu, Patterson, Poole, Kwan, Chen, Weltzien, Pierce, Shu (CR5) 2011; 22 Pierce, Faerber, Wright, Rock, Newman, Flatt, Kealey, Jones, Caan, Gold, Haan, Hollenbach, Jones, Marshall, Ritenbaugh, Stefanick, Thomson, Wasserman, Natarajan, Thomas, Gilpin (CR7) 2002; 23 (CR1) 2008; 67 Patterson, Cadmus, Emond, Pierce (CR18) 2010; 66 Wolf, Hunter, Colditz, Manson, Stampfer, Corsano, Rosner, Kriska, Willett (CR12) 1994; 23 McTiernan, Irwin, VonGruenigen (CR24) 2010; 28 Sternfeld, Weltzien, Quesenberry, Castillo, Kwan, Slattery, Caan (CR26) 2009; 18 ML Irwin (1770_CR23) 2011; 4 JP Pierce (1770_CR21) 2007; 25 BE Ainsworth (1770_CR15) 1993; 25 RE Patterson (1770_CR18) 2010; 66 CE Matthews (1770_CR13) 2003; 158 R DerSimonian (1770_CR17) 1986; 7 1770_CR2 B Sternfeld (1770_CR26) 2009; 18 1770_CR1 1770_CR3 LA Bertram (1770_CR28) 2011; 22 CN Holick (1770_CR27) 2008; 17 AM Wolf (1770_CR12) 1994; 23 1770_CR19 SA Smith-Warner (1770_CR16) 2006; 163 LK Staten (1770_CR10) 2001; 33 JP Pierce (1770_CR7) 2002; 23 O Cheifetz (1770_CR4) 2010; 62 SJ Nechuta (1770_CR5) 2011; 22 MJ Borugian (1770_CR20) 2004; 13 B Caan (1770_CR6) 2005; 16 MD Holmes (1770_CR11) 2005; 293 CM Friedenreich (1770_CR22) 2009; 124 M Johnson-Kozlow (1770_CR14) 2007; 31 GA Colditz (1770_CR8) 2005; 5 A McTiernan (1770_CR24) 2010; 28 XO Shu (1770_CR9) 2009; 302 KH Schmitz (1770_CR25) 2010; 42 |
References_xml | – volume: 13 start-page: 1163 issue: 7 year: 2004 end-page: 1172 ident: CR20 article-title: Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer? publication-title: Cancer Epidemiol Biomarkers Prev – volume: 22 start-page: 427 issue: 3 year: 2011 end-page: 435 ident: CR28 article-title: Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL study publication-title: Cancer Causes Control doi: 10.1007/s10552-010-9714-3 – volume: 23 start-page: 991 issue: 5 year: 1994 end-page: 999 ident: CR12 article-title: Reproducibility and validity of a self-administered physical activity questionnaire publication-title: Int J Epidemiol doi: 10.1093/ije/23.5.991 – ident: CR2 – volume: 67 start-page: 114 issue: 2 year: 2008 end-page: 120 ident: CR1 article-title: To the Secretary of Health and Human Services. Part A: executive summary publication-title: Nutr Rev – volume: 18 start-page: 87 issue: 1 year: 2009 end-page: 95 ident: CR26 article-title: Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-08-0595 – volume: 163 start-page: 1053 issue: 11 year: 2006 end-page: 1064 ident: CR16 article-title: Methods for pooling results of epidemiologic studies: the pooling project of prospective studies of diet and cancer publication-title: Am J Epidemiol doi: 10.1093/aje/kwj127 – volume: 25 start-page: 2345 issue: 17 year: 2007 end-page: 2351 ident: CR21 article-title: Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.6819 – volume: 22 start-page: 1319 issue: 9 year: 2011 end-page: 1331 ident: CR5 article-title: The after breast cancer pooling project: rationale, methodology, and breast cancer survivor characteristics publication-title: Cancer Causes Control doi: 10.1007/s10552-011-9805-9 – volume: 23 start-page: 728 issue: 6 year: 2002 end-page: 756 ident: CR7 article-title: A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women’s healthy eating and living (WHEL) study publication-title: Control Clin Trials doi: 10.1016/S0197-2456(02)00241-6 – volume: 124 start-page: 1954 issue: 8 year: 2009 end-page: 1962 ident: CR22 article-title: Prospective cohort study of lifetime physical activity and breast cancer survival publication-title: Int J Cancer doi: 10.1002/ijc.24155 – volume: 293 start-page: 2479 issue: 20 year: 2005 end-page: 2486 ident: CR11 article-title: Physical activity and survival after breast cancer diagnosis publication-title: JAMA doi: 10.1001/jama.293.20.2479 – volume: 31 start-page: 193 issue: 2 year: 2007 end-page: 202 ident: CR14 article-title: Validation of the WHI brief physical activity questionnaire among women diagnosed with breast cancer publication-title: Am J Health Behav – ident: CR19 – volume: 302 start-page: 2437 issue: 22 year: 2009 end-page: 2443 ident: CR9 article-title: Soy food intake and breast cancer survival publication-title: JAMA doi: 10.1001/jama.2009.1783 – ident: CR3 – volume: 62 start-page: 25 issue: 1 year: 2010 end-page: 34 ident: CR4 article-title: Effects of physical activity on cancer survival: a systematic review publication-title: Physiotherapy Canada doi: 10.3138/physio.62.1.25 – volume: 7 start-page: 177 issue: 3 year: 1986 end-page: 188 ident: CR17 article-title: Meta-analysis in clinical trials publication-title: Control Clin Trials doi: 10.1016/0197-2456(86)90046-2 – volume: 33 start-page: 1959 issue: 11 year: 2001 end-page: 1967 ident: CR10 article-title: Validation of the Arizona activity frequency questionnaire using doubly labeled water publication-title: Med Sci Sports Exerc doi: 10.1097/00005768-200111000-00024 – volume: 25 start-page: 71 issue: 1 year: 1993 end-page: 80 ident: CR15 article-title: Compendium of physical activities: classification of energy costs of human physical activities publication-title: Med Sci Sports Exerc doi: 10.1249/00005768-199301000-00011 – volume: 28 start-page: 4074 issue: 26 year: 2010 end-page: 4080 ident: CR24 article-title: Weight, physical activity, diet, and prognosis in breast and gynecologic cancers publication-title: J Clin Oncol doi: 10.1200/JCO.2010.27.9752 – volume: 16 start-page: 545 issue: 5 year: 2005 end-page: 556 ident: CR6 article-title: Life after cancer epidemiology (LACE) study: a cohort of early stage breast cancer survivors (United States) publication-title: Cancer Causes Control doi: 10.1007/s10552-004-8340-3 – volume: 66 start-page: 5 issue: 1 year: 2010 end-page: 15 ident: CR18 article-title: Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature publication-title: Maturitas doi: 10.1016/j.maturitas.2010.01.004 – volume: 17 start-page: 379 issue: 2 year: 2008 end-page: 386 ident: CR27 article-title: Physical activity and survival after diagnosis of invasive breast cancer publication-title: Cancer Epidemiol Biomarker Prev doi: 10.1158/1055-9965.EPI-07-0771 – volume: 5 start-page: 388 issue: 5 year: 2005 end-page: 396 ident: CR8 article-title: The nurses’ health study: lifestyle and health among women publication-title: Nat Rev Cancer doi: 10.1038/nrc1608 – volume: 42 start-page: 1409 issue: 7 year: 2010 end-page: 1426 ident: CR25 article-title: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors publication-title: Med Sci Sports Exerc doi: 10.1249/MSS.0b013e3181e0c112 – volume: 158 start-page: 1114 issue: 11 year: 2003 end-page: 1122 ident: CR13 article-title: Reproducibility and validity of the Shanghai women’s health study physical activity questionnaire publication-title: Am J Epidemiol doi: 10.1093/aje/kwg255 – volume: 4 start-page: 522 issue: 4 year: 2011 end-page: 529 ident: CR23 article-title: Physical activity and survival in postmenopausal women with breast cancer: results from the women’s health initiative publication-title: Cancer Prev Res (Phila) doi: 10.1158/1940-6207.CAPR-10-0295 – volume: 16 start-page: 545 issue: 5 year: 2005 ident: 1770_CR6 publication-title: Cancer Causes Control doi: 10.1007/s10552-004-8340-3 – ident: 1770_CR2 – volume: 163 start-page: 1053 issue: 11 year: 2006 ident: 1770_CR16 publication-title: Am J Epidemiol doi: 10.1093/aje/kwj127 – volume: 22 start-page: 1319 issue: 9 year: 2011 ident: 1770_CR5 publication-title: Cancer Causes Control doi: 10.1007/s10552-011-9805-9 – volume: 4 start-page: 522 issue: 4 year: 2011 ident: 1770_CR23 publication-title: Cancer Prev Res (Phila) doi: 10.1158/1940-6207.CAPR-10-0295 – volume: 17 start-page: 379 issue: 2 year: 2008 ident: 1770_CR27 publication-title: Cancer Epidemiol Biomarker Prev doi: 10.1158/1055-9965.EPI-07-0771 – volume: 31 start-page: 193 issue: 2 year: 2007 ident: 1770_CR14 publication-title: Am J Health Behav doi: 10.5993/AJHB.31.2.8 – volume: 25 start-page: 71 issue: 1 year: 1993 ident: 1770_CR15 publication-title: Med Sci Sports Exerc doi: 10.1249/00005768-199301000-00011 – volume: 62 start-page: 25 issue: 1 year: 2010 ident: 1770_CR4 publication-title: Physiotherapy Canada doi: 10.3138/physio.62.1.25 – volume: 28 start-page: 4074 issue: 26 year: 2010 ident: 1770_CR24 publication-title: J Clin Oncol doi: 10.1200/JCO.2010.27.9752 – volume: 33 start-page: 1959 issue: 11 year: 2001 ident: 1770_CR10 publication-title: Med Sci Sports Exerc doi: 10.1097/00005768-200111000-00024 – volume: 66 start-page: 5 issue: 1 year: 2010 ident: 1770_CR18 publication-title: Maturitas doi: 10.1016/j.maturitas.2010.01.004 – volume: 124 start-page: 1954 issue: 8 year: 2009 ident: 1770_CR22 publication-title: Int J Cancer doi: 10.1002/ijc.24155 – volume: 293 start-page: 2479 issue: 20 year: 2005 ident: 1770_CR11 publication-title: JAMA doi: 10.1001/jama.293.20.2479 – ident: 1770_CR1 doi: 10.1111/j.1753-4887.2008.00136.x – volume: 25 start-page: 2345 issue: 17 year: 2007 ident: 1770_CR21 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.6819 – volume: 22 start-page: 427 issue: 3 year: 2011 ident: 1770_CR28 publication-title: Cancer Causes Control doi: 10.1007/s10552-010-9714-3 – volume: 5 start-page: 388 issue: 5 year: 2005 ident: 1770_CR8 publication-title: Nat Rev Cancer doi: 10.1038/nrc1608 – volume: 23 start-page: 728 issue: 6 year: 2002 ident: 1770_CR7 publication-title: Control Clin Trials doi: 10.1016/S0197-2456(02)00241-6 – volume: 23 start-page: 991 issue: 5 year: 1994 ident: 1770_CR12 publication-title: Int J Epidemiol doi: 10.1093/ije/23.5.991 – volume: 42 start-page: 1409 issue: 7 year: 2010 ident: 1770_CR25 publication-title: Med Sci Sports Exerc doi: 10.1249/MSS.0b013e3181e0c112 – ident: 1770_CR3 – volume: 18 start-page: 87 issue: 1 year: 2009 ident: 1770_CR26 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-08-0595 – volume: 7 start-page: 177 issue: 3 year: 1986 ident: 1770_CR17 publication-title: Control Clin Trials doi: 10.1016/0197-2456(86)90046-2 – volume: 13 start-page: 1163 issue: 7 year: 2004 ident: 1770_CR20 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.1163.13.7 – volume: 158 start-page: 1114 issue: 11 year: 2003 ident: 1770_CR13 publication-title: Am J Epidemiol doi: 10.1093/aje/kwg255 – ident: 1770_CR19 doi: 10.1007/s12032-010-9536-x – volume: 302 start-page: 2437 issue: 22 year: 2009 ident: 1770_CR9 publication-title: JAMA doi: 10.1001/jama.2009.1783 |
SSID | ssj0009709 |
Score | 2.4192836 |
Snippet | The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to... The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to... The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 hours (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs)... |
SourceID | pubmedcentral proquest gale pubmed pascalfrancis crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 637 |
SubjectTerms | Adult Aged Biological and medical sciences Breast cancer Breast Neoplasms - epidemiology Breast Neoplasms - mortality Breast Neoplasms - rehabilitation Cancer research Cancer therapies Epidemiology Exercise Female Guideline Adherence Guidelines Gynecology. Andrology. Obstetrics Health aspects Humans Mammary gland diseases Medical sciences Medicine Medicine & Public Health Middle Aged Mortality Motor Activity Oncology Patient Compliance Physical fitness Recurrence Risk Factors Surveys Surveys and Questionnaires Toy industry Tumors |
SummonAdditionalLinks | – databaseName: SpringerLINK - Czech Republic Consortium dbid: AGYKE link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9UwFD_IBiKI83vdlxEEQelIv5LWt8vYHMp82mA-lSQ3meLoLmvrg0_-6Z7Tpr123gl7zmmSpicnv9Oc8zsAbzSPdBpFOoyEnoeptjzUQqmQzx1qlJIE4ina4os4Pks_nWfnPo-7HqLdhyvJzlL_leyGvkzYhWBJyUN0edYz9E9wN67PPn79fLjk2pV9ZAdReouci-Eyc1Unk-PIG-WHC1XjArm-ssUq6PlvBOWNa9TudDragNPhvfqglB_7baP3za8blI93fPHH8MijVTbr1esJ3LPVU7h_4u_jn8HvE9ulTDOEkWzhPzmjXAkqScEuWiLRosB6pqo5q1u0Sz9JgAqTM03x8A0zpHfXH1h3e15d1IwyXroOV4gxKglGA_o_SM_h7Ojw9OA49DUdQiOyuAkd4g9rJAIvk-hU5FpmTqZaOYNQL1KF0hY9TpcVai5MkoskVlorzi2eqloilnkBa9VVZTeBuTTKXZpnaZIgqEtjzZ02hVSxTTKXZ0UAfPi0pfGE51R347JcUjXTypa4siWtbBkF8G58ZNGzffxP-BXpS9knrI6WopwlCJJzdLV5AG87CbIVOLJRPuUB50-sWxPJnYkk7nEzad6b6OQ4OXTvY2LcD2B7UNLSG6G6LKIEDSy6oAG8HlupZ4qrq-xVW6Pjh-5iTByCAbBbZLAbSVXfcUFf9lq_HB7hP0HmAORkP4wCRF4-bam-f-tIzJNYxgieAng_KP1y4rcu-dadpLfhAcLbuP9htgNrzXVrdxFCNnrPm4w_FZ9nUA priority: 102 providerName: Springer Nature |
Title | Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project |
URI | https://link.springer.com/article/10.1007/s10549-011-1770-1 https://www.ncbi.nlm.nih.gov/pubmed/21935600 https://www.proquest.com/docview/913319550 https://www.proquest.com/docview/1458527786 https://www.proquest.com/docview/913722299 https://pubmed.ncbi.nlm.nih.gov/PMC3272362 |
Volume | 131 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED-xTUJIE-J7YaMYCQkJZJE4H054Qe3UMoFWIUSl8hTZjjOQUFqWlmf-dO4SJ1Vg21MefLVd39n-ne8L4KX2Ax0FgeZBogseaetznSjF_aJEiVKSQDx5W8yTs0X0cRkvnW9O7dwquzOxOaiLlaE38rcZKlNBhnj6_foXp6JRZFx1FTT24IBCQEn3Sk93Hh6ZbD08KLV3kvpJZ9RsI-dQMeKNP5eUPg8G15I7nA_XqsaFKtsKF1dB0P89Kf8xpza31Owe3HXwko1bebgPt2z1AG6fOwP6Q_hzbpsYZ4a4j60djxgFN1ANCXaxpaxX5AnPVFWweosHyW8ioEriTJMD-4YZEpTLd6wxd1cXNaMQlabDK8gY1fCiAd2TzyNYzKZfT8-4K8LATRKLDS8RMFgjESmZUEdJqmVcykir0iA2C1SmtEUVsYwzVSQmTJNQKK2V71u8BrVE8PEY9qtVZY-AlVGQllEaR2GIKCwS2i-1yaQSNozLNM488Dse5MZlKKdCGT_zXW5lYluObMuJbXngwev-J-s2PcdNxM-JsXkbYdpv7XwcIqpNUTf2PXjVUNDmxpGNcjEKOH9KkzWgPBlQ4qY0g-bRQHj6yaE-LihFvgfHnTTl7tSo817GPXjRt1LP5AhX2dW2Rk0N9TtBSf88YNfQYDeSyrTjgj5pxXM3POJ1wrgeyIHg9gSUbXzYUv343mQdD4UUiHY8eNOJ-G7i1y750xv_5jHcQfwp2hetE9jfXG7tM8R4Gz2CPbmUo2Y_j-BgPJtM5vT98O3TFL-T6fzzF2xdiPFfjodT7g |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ta9RAEB7KFVQQqe-xtV1BEZRgsnnZRChSteVqe4dIC_2W7m42VZDc2dwp_dY_1v_mTLLJEW37rZ8zt7uXmcw-szvzDMBL5fkq9H3l-rHK3VAZz1WxlK6XF2hRUhCIp2yLcTw8DL8cRUdLcNHWwlBaZesTa0edTzSdkb9LMZjyU8TTH6a_XGoaRZerbQcNaTsr5Js1w5it69gzZ38wgqs2dz-jul9xvrN98Gno2iYDro4jPnML3BCNFogEdKDCOFEiKkSoZKERe_gylcpgCFREqcxjHSRxwKVS0vMMunklOPEe4A6wHNL5yQCWP26Pv35bsP6KJseEyMXjxIvba9Wmdg9DM7fOKBPCc_3exmi3h7tTWaGqiqbHxmUg-P9czn8udOt9cmcF7lmAy7Yai7wPS6Z8ALdG9gr_IZyPTF1lzRB5sqm1EkblFdTFgp3MiXeLcvGZLHNWzdGV_SYB6mXOFKXQz5gmUz19z-oL9_KkYlQkUw94iRijLmI0oT10egSHN6KhxzAoJ6V5CqwI_aQIkygMAsSBIVdeoXQqJDdBVCRR6oDX6iDTliOdWnX8zBbszqS2DNWWkdoy34E33U-mDUHIdcIbpNisqXHtnEu2FSCuTjA69xx4XUuQe8GZtbRVErh-IurqSa71JNEt6N7j9Z7xdIvjERVPB9yB1daaMuu3qqz7yhx40T2lkSkVrzSTeYWxIkaYnGgHHWBXyOAwghrF4wt90pjnYnqMGAhlOyB6htsJEN95_0n543vNex5wwRFvOfC2NfHFwq985c-u_ZsbcHt4MNrP9nfHe6twB9Ewb87X1mAwO52b54g4Z2rdftcMjm_alfwFJlaRKw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ta9RAEB5KC0UQ8d3Y2q6gCEow2bxsIhSptkdr7VHEQr-lu5vdKkjubO4Uv_n3_FfOJJsc0bbf-jlzu3uZyewzuzPPADxTQajiMFR-mKrSj5UJfJVK6QelRYuSgkA8ZVuM073j-MNJcrIEf7paGEqr7Hxi46jLiaYz8tc5BlNhTqTa1mVFHO2M3k6_-9RAii5au24a0nVZKLcatjFX43Fgfv3EaK7e2t9B1T_nfLT7-f2e7xoO-DpN-My3uDkaLRAV6EjFaaZEYkWspNWIQ0KZS2UwHLJJLstUR1kacamUDAKDLl8JThwIuBusCNz0MQ5cebc7Pvq0YAAWbb4JEY2nWZB2V6xtHR-GaX6TXSZE4IeDTdJtFTenska12bbfxkWA-P-8zn8ud5s9c3Qbbjmwy7Zb67wDS6a6C6uH7jr_Hvw-NE3FNUMUyqbOYhiVWlBHC3Y2Jw4uystnsipZPUe39oMEqK85U5ROP2OazPb8DWsu36uzmlHBTDPgBWKMOorRhO4A6j4cX4uGHsByNanMI2A2DjMbZ0kcRYgJY64Cq3QuJDdRYrMk9yDodFBox5dObTu-FQumZ1JbgWorSG1F6MHL_ifTlizkKuFNUmzR1rv2jqbYjhBjZxipBx68aCTI1eDMWrqKCVw_kXYNJNcHkugi9ODxxsB4-sXxhAqpI-7BWmdNhfNhddF_cR487Z_SyJSWV5nJvMa4EaNNThSEHrBLZHAYQU3j8YU-bM1zMT1GD4S4PRADw-0FiPt8-KT6-qXhQI-44Ii9PHjVmfhi4Ze-8sdX_s1NWEWXUnzcHx-swQ0Exrw9aluH5dn53DxB8DlTG-6zZnB63Z7kL2ZSlW8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Meeting+the+physical+activity+guidelines+and+survival+after+breast+cancer%3A+findings+from+the+after+breast+cancer+pooling+project&rft.jtitle=Breast+cancer+research+and+treatment&rft.au=Beasley%2C+Jeannette+M&rft.au=Kwan%2C+Marilyn+L&rft.au=Chen%2C+Wendy+Y&rft.au=Weltzien%2C+Erin+K&rft.date=2012-01-01&rft.pub=Springer&rft.issn=0167-6806&rft.volume=131&rft.issue=2&rft.spage=637&rft_id=info:doi/10.1007%2Fs10549-011-1770-1&rft.externalDocID=A356581060 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-6806&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-6806&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-6806&client=summon |